P05696 (KPCA_RAT) Reviewed, UniProtKB/Swiss-Prot
Last modified
January 25, 2012.
Version 136.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Protein kinase C alpha type Short name=PKC-A Short name=PKC-alpha EC=2.7.11.13 | ||||
| Gene names |
| ||||
| Organism | Rattus norvegicus (Rat) | ||||
| Taxonomic identifier | 10116 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Glires › Rodentia › Sciurognathi › Muroidea › Muridae › Murinae › Rattus |
Protein attributes
| Sequence length | 672 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Calcium-activated, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that is involved in positive and negative regulation of cell proliferation, apoptosis, differentiation, migration and adhesion, cardiac hypertrophy, angiogenesis, platelet function and inflammation, by directly phosphorylating targets such as RAF1, BCL2, CSPG4, TNNT2/CTNT, or activating signaling cascade involving MAPK1/3 (ERK1/2) and RAP1GAP. Depending on the cell type, is involved in cell proliferation and cell growth arrest by positive and negative regulation of the cell cycle. Can promote cell growth by phosphorylating and activating RAF1, which mediates the activation of the MAPK/ERK signaling cascade, and/or by up-regulating CDKN1A, which facilitates active cyclin-dependent kinase (CDK) complex formation. In cells stimulated by the phorbol ester PMA, can trigger a cell cycle arrest program which is associated with the accumulation of the hyper-phosphorylated growth-suppressive form of RB1 and induction of the CDK inhibitors CDKN1A and CDKN1B. Depending on the cell type, exhibits anti-apoptotic function and protects cells from apoptosis by suppressing the p53/TP53-mediated activation of IGFBP3, or mediates anti-apoptotic action by phosphorylating BCL2. During macrophage differentiation induced by macrophage colony-stimulating factor (CSF1), is translocated to the nucleus and is associated with macrophage development. After wounding, translocates from focal contacts to lamellipodia and participates in the modulation of desmosomal adhesion. Plays a role in cell motility by phosphorylating CSPG4, which induces association of CSPG4 with extensive lamellipodia at the cell periphery and polarization of the cell accompanied by increases in cell motility. Negatively regulates myocardial contractility and positively regulates angiogenesis, platelet aggregation and thrombus formation in arteries. Mediates hypertrophic growth of neonatal cardiomyocytes, in part through a MAPK1/3 (ERK1/2)-dependent signaling pathway, and upon PMA treatment, is required to induce cardiomyocyte hypertrophy up to heart failure and death, by increasing protein synthesis, protein-DNA ratio and cell surface area. Regulates cardiomyocyte function by phosphorylating cardiac troponin T (TNNT2/CTNT), which induces significant reduction in actomyosin ATPase activity, myofilament calcium sensitivity and myocardial contractility. In angiogenesis, is required for full endothelial cell migration, adhesion to vitronectin (VTN), and vascular endothelial growth factor A (VEGFA)-dependent regulation of kinase activation and vascular tube formation. Involved in the stabilization of VEGFA mRNA at post-transcriptional level and mediates VEGFA-induced cell proliferation. In the regulation of calcium-induced platelet aggregation, mediates signals from the CD36/GP4 receptor for granule release, and activates the integrin heterodimer ITGA2B-ITGB3 through the RAP1GAP pathway for adhesion. During response to lipopolysaccharides (LPS), may regulate selective LPS-induced macrophage functions involved in host defense and inflammation. But in some inflammatory responses, may negatively regulate NF-kappa-B-induced genes, through IL1A-dependent induction of NF-kappa-B inhibitor alpha (NFKBIA/IKBA). Upon stimulation with 12-O-tetradecanoylphorbol-13-acetate (TPA), phosphorylates EIF4G1, which modulates EIF4G1 binding to MKNK1 and may be involved in the regulation of EIF4E phosphorylation. Phosphorylates KIT, leading to inhibition of KIT activity. Ref.4 Ref.5 Ref.6 |
| Catalytic activity | ATP + a protein = ADP + a phosphoprotein. |
| Cofactor | Binds 3 calcium ions per subunit. The ions are bound to the C2 domain By similarity. |
| Enzyme regulation | Classical (or conventional) PKCs (PRKCA, PRKCB and PRKCG) are activated by calcium and diacylglycerol (DAG) in the presence of phosphatidylserine. Three specific sites; Thr-497 (activation loop of the kinase domain), Thr-638 (turn motif) and Ser-657 (hydrophobic region), need to be phosphorylated for its full activation. |
| Subunit structure | Interacts with ADAP1/CENTA1, CSPG4 and PRKCABP. Binds to SDPR in the presence of phosphatidylserine By similarity. Interacts with PICK1 (via PDZ domain) By similarity. Interacts with TRIM41 By similarity. Recruited in a circadian manner into a nuclear complex which also includes BMAL1 and GNB2L1/RACK1 By similarity. Ref.3 |
| Subcellular location | Cytoplasm. Cell membrane; Peripheral membrane protein. Mitochondrion membrane; Peripheral membrane protein By similarity. Nucleus. Note: Translocated to the nucleus upon treatment with PMA or IGF1. Ref.6 Ref.9 |
| Sequence similarities | Belongs to the protein kinase superfamily. AGC Ser/Thr protein kinase family. PKC subfamily. Contains 1 AGC-kinase C-terminal domain. Contains 1 C2 domain. Contains 2 phorbol-ester/DAG-type zinc fingers. Contains 1 protein kinase domain. |
Ontologies
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Initiator methionine | 1 | 1 | Removed By similarity | |||||||||||||||||||||||||||||
| Chain | 2 – 672 | 671 | Protein kinase C alpha type | PRO_0000055682 | ||||||||||||||||||||||||||||
Regions | ||||||||||||||||||||||||||||||||
| Domain | 172 – 260 | 89 | C2 | |||||||||||||||||||||||||||||
| Domain | 339 – 597 | 259 | Protein kinase | |||||||||||||||||||||||||||||
| Domain | 598 – 668 | 71 | AGC-kinase C-terminal | |||||||||||||||||||||||||||||
| Zinc finger | 36 – 86 | 51 | Phorbol-ester/DAG-type 1 | |||||||||||||||||||||||||||||
| Zinc finger | 101 – 151 | 51 | Phorbol-ester/DAG-type 2 | |||||||||||||||||||||||||||||
| Nucleotide binding | 345 – 353 | 9 | ATP By similarity | |||||||||||||||||||||||||||||
Sites | ||||||||||||||||||||||||||||||||
| Active site | 463 | 1 | Proton acceptor By similarity | |||||||||||||||||||||||||||||
| Metal binding | 186 | 1 | Calcium 1; via carbonyl oxygen | |||||||||||||||||||||||||||||
| Metal binding | 187 | 1 | Calcium 1 | |||||||||||||||||||||||||||||
| Metal binding | 187 | 1 | Calcium 2 | |||||||||||||||||||||||||||||
| Metal binding | 193 | 1 | Calcium 2 | |||||||||||||||||||||||||||||
| Metal binding | 246 | 1 | Calcium 1 | |||||||||||||||||||||||||||||
| Metal binding | 246 | 1 | Calcium 2 | |||||||||||||||||||||||||||||
| Metal binding | 247 | 1 | Calcium 2; via carbonyl oxygen | |||||||||||||||||||||||||||||
| Metal binding | 248 | 1 | Calcium 1 | |||||||||||||||||||||||||||||
| Metal binding | 248 | 1 | Calcium 2 | |||||||||||||||||||||||||||||
| Metal binding | 248 | 1 | Calcium 3 | |||||||||||||||||||||||||||||
| Metal binding | 252 | 1 | Calcium 3; via carbonyl oxygen | |||||||||||||||||||||||||||||
| Metal binding | 254 | 1 | Calcium 1 | |||||||||||||||||||||||||||||
| Metal binding | 254 | 1 | Calcium 3 | |||||||||||||||||||||||||||||
| Binding site | 195 | 1 | Inositol phosphate group | |||||||||||||||||||||||||||||
| Binding site | 245 | 1 | Inositol phosphate group | |||||||||||||||||||||||||||||
| Binding site | 368 | 1 | ATP By similarity | |||||||||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||||||||
| Modified residue | 2 | 1 | N-acetylalanine By similarity | |||||||||||||||||||||||||||||
| Modified residue | 195 | 1 | Phosphotyrosine By similarity | |||||||||||||||||||||||||||||
| Modified residue | 208 | 1 | Phosphoserine By similarity | |||||||||||||||||||||||||||||
| Modified residue | 226 | 1 | Phosphoserine By similarity | |||||||||||||||||||||||||||||
| Modified residue | 250 | 1 | Phosphothreonine; by autocatalysis By similarity | |||||||||||||||||||||||||||||
| Modified residue | 319 | 1 | Phosphoserine By similarity | |||||||||||||||||||||||||||||
| Modified residue | 494 | 1 | Phosphothreonine By similarity | |||||||||||||||||||||||||||||
| Modified residue | 495 | 1 | Phosphothreonine By similarity | |||||||||||||||||||||||||||||
| Modified residue | 497 | 1 | Phosphothreonine; by PDPK1 By similarity | |||||||||||||||||||||||||||||
| Modified residue | 501 | 1 | Phosphothreonine By similarity | |||||||||||||||||||||||||||||
| Modified residue | 604 | 1 | N6-acetyllysine By similarity | |||||||||||||||||||||||||||||
| Modified residue | 628 | 1 | N6-acetyllysine By similarity | |||||||||||||||||||||||||||||
| Modified residue | 631 | 1 | Phosphothreonine; by autocatalysis Potential | |||||||||||||||||||||||||||||
| Modified residue | 638 | 1 | Phosphothreonine; by autocatalysis By similarity | |||||||||||||||||||||||||||||
| Modified residue | 657 | 1 | Phosphoserine By similarity | |||||||||||||||||||||||||||||
| Modified residue | 658 | 1 | Phosphotyrosine; by SYK By similarity | |||||||||||||||||||||||||||||
Experimental info | ||||||||||||||||||||||||||||||||
| Mutagenesis | 195 | 1 | Y → S: Reduced phosphatidylinositol 4,5-bisphosphate recognition and impaired membrane docking. Loss of phosphatidylinositol 4,5-bisphosphate-binding and strong decrease of membrane docking; when associated with A-209; A-211 and A-245. Ref.9 | |||||||||||||||||||||||||||||
| Mutagenesis | 209 | 1 | K → A: Loss of phosphatidylinositol 4,5-bisphosphate-binding and strong decrease of membrane docking; when associated with S-195; A-211 and A-245. Ref.9 | |||||||||||||||||||||||||||||
| Mutagenesis | 211 | 1 | K → A: Loss of phosphatidylinositol 4,5-bisphosphate-binding and strong decrease of membrane docking; when associated with S-195; A-209 and A-245. Ref.9 | |||||||||||||||||||||||||||||
| Mutagenesis | 245 | 1 | W → A: Reduced phosphatidylinositol 4,5-bisphosphate recognition and impaired membrane docking. Loss of phosphatidylinositol 4,5-bisphosphate-binding and strong decrease of membrane docking; when associated with S-195; A-209 and A-211. Ref.9 | |||||||||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||||||||
| Beta strand | 161 – 168 | 8 | ||||||||||||||||||||||||||||||
| Beta strand | 170 – 182 | 13 | ||||||||||||||||||||||||||||||
| Beta strand | 194 – 202 | 9 | ||||||||||||||||||||||||||||||
| Beta strand | 222 – 230 | 9 | ||||||||||||||||||||||||||||||
| Helix | 233 – 235 | 3 | ||||||||||||||||||||||||||||||
| Beta strand | 239 – 246 | 8 | ||||||||||||||||||||||||||||||
| Beta strand | 249 – 251 | 3 | ||||||||||||||||||||||||||||||
| Beta strand | 254 – 262 | 9 | ||||||||||||||||||||||||||||||
| Helix | 263 – 268 | 6 | ||||||||||||||||||||||||||||||
| Beta strand | 271 – 276 | 6 | ||||||||||||||||||||||||||||||
| Helix | 280 – 283 | 4 | ||||||||||||||||||||||||||||||
| Beta strand | 288 – 290 | 3 | ||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| [1] | "Nucleotide sequences of cDNAs for alpha and gamma subspecies of rat brain protein kinase C." Ono Y., Fujii T., Igarashi K., Kikkawa U., Ogita K., Nishizuka Y. Nucleic Acids Res. 16:5199-5200(1988) [PubMed: 3387228] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Tissue: Brain. |
| [2] | "The common structure and activities of four subspecies of rat brain protein kinase C family." Kikkawa U., Ogita K., Ono Y., Asaoka Y., Shearman M.S., Fujii T., Ase K., Sekiguchi K., Igarashi K., Nishizuka Y. FEBS Lett. 223:212-216(1987) [PubMed: 3666147] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Tissue: Brain. |
| [3] | "Targeting of protein kinase Calpha to caveolae." Mineo C., Ying Y.-S., Chapline C., Jaken S., Anderson R.G.W. J. Cell Biol. 141:601-610(1998) [PubMed: 9566962] [Abstract] Cited for: INTERACTION WITH SDPR. |
| [4] | "Protein kinase C signaling mediates a program of cell cycle withdrawal in the intestinal epithelium." Frey M.R., Clark J.A., Leontieva O., Uronis J.M., Black A.R., Black J.D. J. Cell Biol. 151:763-778(2000) [PubMed: 11076962] [Abstract] Cited for: FUNCTION IN CELL CYCLE ARREST. |
| [5] | "PKC alpha regulates the hypertrophic growth of cardiomyocytes through extracellular signal-regulated kinase1/2 (ERK1/2)." Braz J.C., Bueno O.F., De Windt L.J., Molkentin J.D. J. Cell Biol. 156:905-919(2002) [PubMed: 11864993] [Abstract] Cited for: FUNCTION IN CARDIAC HYPETROPHY. |
| [6] | "Protein kinase C-alpha-induced hypertrophy of neonatal rat ventricular myocytes." Vijayan K., Szotek E.L., Martin J.L., Samarel A.M. Am. J. Physiol. 287:H2777-H2789(2004) [PubMed: 15271671] [Abstract] Cited for: FUNCTION IN HEART FAILURE, SUBCELLULAR LOCATION. |
| [7] | "The molecular heterogeneity of protein kinase C and its implications for cellular regulation." Nishizuka Y. Nature 334:661-665(1988) [PubMed: 3045562] [Abstract] Cited for: REVIEW. |
| [8] | "Ca(2+) bridges the C2 membrane-binding domain of protein kinase Calpha directly to phosphatidylserine." Verdaguer N., Corbalan-Garcia S., Ochoa W.F., Fita I., Gomez-Fernandez J.C. EMBO J. 18:6329-6338(1999) [PubMed: 10562545] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 155-293 IN COMPLEX WITH PHOSPHATIDYLSERINE. |
| [9] | "Structural and mechanistic insights into the association of PKCalpha-C2 domain to PtdIns(4,5)P2." Guerrero-Valero M., Ferrer-Orta C., Querol-Audi J., Marin-Vicente C., Fita I., Gomez-Fernandez J.C., Verdaguer N., Corbalan-Garcia S. Proc. Natl. Acad. Sci. U.S.A. 106:6603-6607(2009) [PubMed: 19346474] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 156-292 IN COMPLEX WITH PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE, MUTAGENESIS OF TYR-195; LYS-209; LYS-211 AND TRP-245, SUBCELLULAR LOCATION. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | X07286 mRNA. Translation: CAA30266.1. | ||||||||||||||||||||||||||||||
| IPI | IPI00201792. | ||||||||||||||||||||||||||||||
| PIR | KIRTC. S02248. | ||||||||||||||||||||||||||||||
| UniGene | Rn.207908. | ||||||||||||||||||||||||||||||
3D structure databases | |||||||||||||||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||||||||||||||
| ProteinModelPortal | P05696. | ||||||||||||||||||||||||||||||
| SMR | P05696. Positions 37-292, 336-666. | ||||||||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||||||||||||||
| IntAct | P05696. 2 interactions. | ||||||||||||||||||||||||||||||
| MINT | MINT-86103. | ||||||||||||||||||||||||||||||
| STRING | P05696. | ||||||||||||||||||||||||||||||
PTM databases | |||||||||||||||||||||||||||||||
| PhosphoSite | P05696. | ||||||||||||||||||||||||||||||
Proteomic databases | |||||||||||||||||||||||||||||||
| PRIDE | P05696. | ||||||||||||||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||||||||||||||
Organism-specific databases | |||||||||||||||||||||||||||||||
| RGD | 3395. Prkca. | ||||||||||||||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||||||||||||||
| eggNOG | maNOG08253. | ||||||||||||||||||||||||||||||
| GeneTree | ENSGT00590000082854. | ||||||||||||||||||||||||||||||
| HOVERGEN | HBG108317. | ||||||||||||||||||||||||||||||
| OrthoDB | EOG40ZQX0. | ||||||||||||||||||||||||||||||
| PhylomeDB | P05696. | ||||||||||||||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||||||||||||||
| BRENDA | 2.7.11.13. 5301. | ||||||||||||||||||||||||||||||
Gene expression databases | |||||||||||||||||||||||||||||||
| ArrayExpress | P05696. | ||||||||||||||||||||||||||||||
| Genevestigator | P05696. | ||||||||||||||||||||||||||||||
| GermOnline | ENSRNOG00000003491. Rattus norvegicus. | ||||||||||||||||||||||||||||||
Family and domain databases | |||||||||||||||||||||||||||||||
| InterPro | IPR000961. AGC-kinase_C. IPR000008. C2_Ca-dep. IPR008973. C2_Ca/lipid-bd_dom_CaLB. IPR020477. C2_dom. IPR018029. C2_membr_targeting. IPR020454. DAG/PE-bd. IPR011009. Kinase-like_dom. IPR017892. Pkinase_C. IPR002219. Prot_Kinase_C-like_PE/DAG-bd. IPR000719. Prot_kinase_cat_dom. IPR017441. Protein_kinase_ATP_BS. IPR014375. Protein_kinase_C_a/b/g. IPR017442. Se/Thr_kinase-like_dom. IPR008271. Ser/Thr_kinase_AS. IPR002290. Ser/Thr_kinase_dom. [Graphical view] | ||||||||||||||||||||||||||||||
| Pfam | PF00130. C1_1. 2 hits. PF00168. C2. 1 hit. PF00069. Pkinase. 1 hit. PF00433. Pkinase_C. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||
| PIRSF | PIRSF000550. PKC_alpha. 1 hit. | ||||||||||||||||||||||||||||||
| PRINTS | PR00360. C2DOMAIN. PR00008. DAGPEDOMAIN. | ||||||||||||||||||||||||||||||
| SMART | SM00109. C1. 2 hits. SM00239. C2. 1 hit. SM00133. S_TK_X. 1 hit. SM00220. S_TKc. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||
| SUPFAM | SSF49562. C2_CaLB. 1 hit. SSF56112. Kinase_like. 1 hit. | ||||||||||||||||||||||||||||||
| PROSITE | PS51285. AGC_KINASE_CTER. 1 hit. PS50004. C2. 1 hit. PS00107. PROTEIN_KINASE_ATP. 1 hit. PS50011. PROTEIN_KINASE_DOM. 1 hit. PS00108. PROTEIN_KINASE_ST. 1 hit. PS00479. ZF_DAG_PE_1. 2 hits. PS50081. ZF_DAG_PE_2. 2 hits. [Graphical view] | ||||||||||||||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||||||||||||||
Entry information
| Entry name | KPCA_RAT | ||||||||
| Accession | Primary (citable) accession number: P05696 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
Relevant documents
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with